Abivax SA (ABVX)
125.70
+6.74
(+5.67%)
USD |
NASDAQ |
Apr 09, 16:00
125.70
0.00 (0.00%)
After-Hours: 18:21
Abivax Total Liabilities (Quarterly) : 151.66M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AstraZeneca PLC | 65.30B |
| Eli Lilly & Co. | 85.94B |
| DBV Technologies SA | 64.95M |
| Insmed, Inc. | 1.526B |
| Nicox SA | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 686.28M |
| Shareholders Equity (Quarterly) | 534.62M |
| Debt to Equity Ratio | 0.0705 |
| Current Ratio | 8.747 |
| Net Debt Paydown Yield | 0.14% |